Lilly’s legal offensive against compounders of its popular weight loss drugs hits another snag in court.

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S.

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell ...

Demand for popular weight loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) has long outpaced supply, forcing many patients with obesity to visit compounding pharmacies to get ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...

Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many concerns about safety still swirl around these forms of the medications.

ABC News' Juju Chang investigates the digital market for counterfeit weight-loss medications, as well as the warning signs to ...

Compounded medications are not FDA-approved. This means they haven’t undergone the same rigorous testing for safety and effectiveness. The FDA advises against using compounded versions unless approved ...

EMINENCE, Ky. (WDRB) -- The investigation to an "alleged medication error" continues in Henry County. In an emergency called meeting on Aug. 28, the Kentucky Board of Pharmacy ordered Med Save ...